Xopenex and Multiple sclerosis aggravated - a phase IV clinical study of FDA data

Summary:

Multiple sclerosis aggravated is reported as a side effect among people who take Xopenex (levalbuterol hydrochloride), especially for people who are female, 30-39 old, also take Singulair, and have Narcolepsy.

The phase IV clinical study analyzes which people have Multiple sclerosis aggravated when taking Xopenex. It is created by eHealthMe based on reports of 13,420 people who have side effects when taking Xopenex from the FDA, and is updated regularly.

What is Xopenex?

Xopenex has active ingredients of levalbuterol hydrochloride. It is often used in asthma. eHealthMe is studying from 13,816 Xopenex users. Check the latest studies of Xopenex.

What is Multiple sclerosis aggravated?

Multiple sclerosis aggravated (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,023 drugs and 322 conditions by eHealthMe. Check the latest studies of Multiple sclerosis aggravated.

On Jul, 16, 2026

13,420 people reported to have side effects when taking Xopenex.
Among them, 35 people (0.26%) have Multiple sclerosis aggravated.

Could Xopenex cause Multiple sclerosis aggravated?

Among these 35 people:

What is the gender of people who have Multiple sclerosis aggravated when taking Xopenex? *

female: 97.14 %
male: 2.86 %

What is the age of people who have Multiple sclerosis aggravated when taking Xopenex? *

What are other drugs people take besides Xopenex? *

Singulair: 19 people, 54.29%
Xyrem: 16 people, 45.71%
Aubagio: 14 people, 40.00%
Hydrocodone Bitartrate And Acetaminophen: 14 people, 40.00%
Oxycontin: 14 people, 40.00%
Soma: 13 people, 37.14%
Ampyra: 13 people, 37.14%
Neurontin: 12 people, 34.29%
Zyrtec: 12 people, 34.29%
Lortab: 12 people, 34.29%

What are other side effects people have besides Multiple sclerosis aggravated? *

High Blood Pressure: 15 people, 42.86%
Insomnia (sleeplessness): 13 people, 37.14%
Therapeutic Response Unexpected: 13 people, 37.14%
Skin Disorder (skin disease): 11 people, 31.43%
Chest Pain: 10 people, 28.57%
Weakness: 7 people, 20.00%
Pain: 7 people, 20.00%
Fatigue (feeling of tiredness): 7 people, 20.00%
Fever: 6 people, 17.14%
Pneumonia: 5 people, 14.29%

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 16 people, 45.71%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 14 people, 40.00%
High Blood Cholesterol: 2 people, 5.71%
Tremor (trembling or shaking movements in one or more parts of your body): 2 people, 5.71%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 5.71%
Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 5.71%
Pain: 2 people, 5.71%
Diabetes: 2 people, 5.71%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 5.71%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 2.86%

* Approximation only. Some reports may have incomplete information.

Do you take Xopenex and have Multiple sclerosis aggravated?

- Check whether Multiple sclerosis aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Xopenex:

Xopenex (13,816 reports)

Browse all side effects of Xopenex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Multiple sclerosis aggravated:

Multiple sclerosis aggravated (1,023 drugs)

Browse all the conditions that are associated with Multiple sclerosis aggravated:

Multiple sclerosis aggravated (322 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on levalbuterol hydrochloride (the active ingredients of Xopenex) and Xopenex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.